Sentara Infusion Services recalls CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR, antibiotic, Sentara Home Infusion Pharmacy Services, 535 Independence Pkw
Recalled February 22, 2023 · FDA recall D-0279-2023 · Sentara Infusion Services
Hazard
Lack of sterility assurance · FDA Class II
Units
8 syringes
Sold at
Dispensed to Patients Nationwide.
Description
Lack of sterility assurance
Product
CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR, antibiotic, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Manufacturer(s)
Sentara Infusion Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →